Building up cancer research in Portugal
Cancer is a leading cause of death worldwide, and despite extensive research, many aspects regarding cancer biology and metastasis remain unclear. Understanding the mechanisms involved in tumour progression, resistance and relapse is paramount for designing novel therapies. The EU-funded QuantOCancer project aims to reinforce the capacity-building of the Champalimaud Foundation in Portugal in performing genetic, modelling, imaging and quantitative research with a focus on cancer. The research programme will bridge and transform different research operations at the Foundation. Overseas training and networking opportunities will further reinforce research potential and excellence.
- H2020-EU.4.c. - Establishing ‚ERA Chairs’ Main Programme
Call for proposalSee other projects for this call